{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:04:54Z","timestamp":1767211494647,"version":"3.44.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/I014608\/1"],"award-info":[{"award-number":["BB\/I014608\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20581"],"award-info":[{"award-number":["20581"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ajpath.2018.12.007","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T21:31:39Z","timestamp":1547847099000},"page":"753-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-3104","authenticated-orcid":false,"given":"Behzad","family":"Javaheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hopkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-Jazzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Pitsillides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2018.12.007_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(05)17989-6","article-title":"Optimised glucocorticoid therapy: the sharpening of an old spear","volume":"365","author":"Buttgereit","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2018.12.007_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/s10165-008-0096-2","article-title":"Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry","volume":"18","author":"Ogoshi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S8756-3282(02)00737-8","article-title":"Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers","volume":"30","author":"McLaughlin","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2018.12.007_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14656566.2013.761975","article-title":"Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions","volume":"14","author":"Bultink","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajpath.2018.12.007_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bone.2005.10.004","article-title":"Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells","volume":"38","author":"Humphrey","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2018.12.007_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2018.12.007_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3892\/ijmm.2015.2432","article-title":"Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway","volume":"37","author":"Chen","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2018.12.007_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0049-0172(05)80029-0","article-title":"Corticosteroid-induced osteoporosis","volume":"22","author":"Adachi","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2018.12.007_bib9","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/S0002-9343(97)90006-1","article-title":"Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence","volume":"103","author":"Saag","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpath.2018.12.007_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2018.12.007_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14728220902841961","article-title":"Wnt signaling as a therapeutic target for bone diseases","volume":"13","author":"Hoeppner","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ajpath.2018.12.007_bib13","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/art.23454","article-title":"Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2018.12.007_bib14","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1038\/sj.ijo.0801284","article-title":"Glucocorticoids and neuroendocrine function","volume":"24","author":"Cavagnini","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ajpath.2018.12.007_bib15","first-page":"205","article-title":"Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy","volume":"1","author":"Georgiou","year":"2012","journal-title":"Am J Stem Cells"},{"key":"10.1016\/j.ajpath.2018.12.007_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrrheum.2009.259","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"6","author":"Compston","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.22660","article-title":"Antagonistic interplay between mechanical forces and glucocorticoids in bone: a tale of kinases","volume":"111","author":"Bellido","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib18","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis","volume":"282","author":"Plotkin","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib19","series-title":"Glucocorticoid-induced bone disease. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"473","author":"Weinstein","year":"2013"},{"key":"10.1016\/j.ajpath.2018.12.007_bib20","first-page":"1812","article-title":"Wnt signaling and glucocorticoid-induced osteoporosis","volume":"16","author":"Ohnaka","year":"2006","journal-title":"Clin Calcium"},{"key":"10.1016\/j.ajpath.2018.12.007_bib21","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2018.12.007_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10067-006-0315-1","article-title":"Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures","volume":"26","author":"Gourlay","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jbmr.2064","article-title":"Deletion of a single \u03b2-catenin allele in osteocytes abolishes the bone anabolic response to loading","volume":"29","author":"Javaheri","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib24","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1038\/s41598-018-25084-6","article-title":"Transient peak-strain matching partially recovers the age-impaired mechanoadaptive cortical bone response","volume":"8","author":"Javaheri","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2018.12.007_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin expression and functions beyond the osteocyte","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2018.12.007_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bone.2005.02.019","article-title":"A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene","volume":"36","author":"Balemans","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2018.12.007_bib27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2018.12.007_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","article-title":"Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor","volume":"157","author":"Kato","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/me.2003-0498","article-title":"The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice","volume":"18","author":"Bodine","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant LRP5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2018.12.007_bib33","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","article-title":"Essential role of beta-catenin in postnatal bone acquisition","volume":"280","author":"Holmen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1359\/JBMR.040816","article-title":"LRP5 and Wnt signaling: a union made for bone","volume":"19","author":"Johnson","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib35","doi-asserted-by":"crossref","first-page":"20715","DOI":"10.1074\/jbc.M703224200","article-title":"Wnt\/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha","volume":"282","author":"Armstrong","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib36","first-page":"S60","article-title":"The human LRP5 G171V mutation in mice alters the skeletal response to limb unloading but not to ovariectomy","volume":"18","author":"Bex","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib37","doi-asserted-by":"crossref","first-page":"31720","DOI":"10.1016\/S0021-9258(19)84086-3","article-title":"Wnt\/beta-catenin signaling is a normal physiological response to mechanical loading in bone","volume":"281","author":"Robinson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib38","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M601000200","article-title":"The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment","volume":"281","author":"Sawakami","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2018.12.007_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fmats.2017.00027","article-title":"Sost deficiency does not alter bone's lacunar or vascular porosity in Mice","volume":"4","author":"Mosey","year":"2017","journal-title":"Front Mater"},{"key":"10.1016\/j.ajpath.2018.12.007_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2018.12.007_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","article-title":"Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength","volume":"27","author":"Yao","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2018.12.007_bib42","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/art.30385","article-title":"Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone","volume":"63","author":"Marenzana","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2018.12.007_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","article-title":"Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover","volume":"57","author":"Gifre","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2018.12.007_bib44","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00198-013-2268-y","article-title":"Serum extracellular secreted antagonists of the canonical Wnt\/\u03b2-catenin signaling pathway in patients with Cushing's syndrome","volume":"24","author":"Belaya","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2018.12.007_bib45","doi-asserted-by":"crossref","first-page":"E1953","DOI":"10.1210\/jc.2012-2218","article-title":"Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment","volume":"97","author":"Van Lierop","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2018.12.007_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1210\/en.2013-1247","article-title":"An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess","volume":"155","author":"Bentley","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2018.12.007_bib47","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bone.2011.06.031","article-title":"Development of micro-CT protocols for in\u00a0vivo follow-up of mouse bone architecture without major radiation side effects","volume":"49","author":"Laperre","year":"2011","journal-title":"Bone"},{"year":"2014","series-title":"A Practical Guide to the Histology of the Mouse","author":"Scudamore","key":"10.1016\/j.ajpath.2018.12.007_bib49"},{"key":"10.1016\/j.ajpath.2018.12.007_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2018.12.007_bib51","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M110.001693","article-title":"Proteomic characterization of extracellular space components in the human aorta","volume":"9","author":"Didangelos","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2018.12.007_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","article-title":"Carcinogenicity risk assessment of romosozumab: a review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study","volume":"81","author":"Chouinard","year":"2016","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot\u2013containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2018.12.007_bib54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00256-003-0675-4","article-title":"Van Buchem disease: lifetime evolution of radioclinical features","volume":"32","author":"Vanhoenacker","year":"2003","journal-title":"Skeletal Radiol"},{"year":"1976","series-title":"Hyperostosis Corticalis Generalisata Familiaris (van Buchem's Disease)","author":"Van Buchem","key":"10.1016\/j.ajpath.2018.12.007_bib55"},{"key":"10.1016\/j.ajpath.2018.12.007_bib56","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerosteosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.ajpath.2018.12.007_bib58","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/jbmr.151","article-title":"Glucocorticoids are not always deleterious for bone","volume":"25","author":"van Lierop","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib59","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of Sost\/Sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib60","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ajpath.2018.12.007_bib61","doi-asserted-by":"crossref","first-page":"F477","DOI":"10.1152\/ajprenal.00472.2015","article-title":"Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing","volume":"310","author":"Rukov","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib62","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/jbmr.1994","article-title":"Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease","volume":"28","author":"Kramann","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"Brandenburg","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Ominsky","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib65","doi-asserted-by":"crossref","first-page":"e0199504","DOI":"10.1371\/journal.pone.0199504","article-title":"Circulating levels of sclerostin are associated with cardiovascular mortality","volume":"13","author":"Novo-Rodr\u00edguez","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ajpath.2018.12.007_bib66","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3892\/mmr.2017.6390","article-title":"Sclerostin is a possible candidate marker of arterial stiffness: results from a cohort study in Catania","volume":"15","author":"Gaudio","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ajpath.2018.12.007_bib67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/ATVBAHA.116.308723","article-title":"Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II\u2013induced aortic aneurysm and atherosclerosis","volume":"37","author":"Krishna","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2018.12.007_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","article-title":"The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus","volume":"11","author":"Gaudio","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.ajpath.2018.12.007_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1097-0142(19930101)71:1<93::AID-CNCR2820710115>3.0.CO;2-R","article-title":"Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion","volume":"71","author":"Okamoto","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2018.12.007_bib70","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.53.5.896","article-title":"Uremic pericarditis as a cause of cardiac tamponade","volume":"53","author":"Baldwin","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2018.12.007_bib71","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archinte.1987.00370060163027","article-title":"Hypothyroid cardiac tamponade","volume":"147","author":"Manolis","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajpath.2018.12.007_bib72","first-page":"398","article-title":"Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients","volume":"31","author":"Kabukcu","year":"2004","journal-title":"Tex Heart Inst J"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018306977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018306977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:32:02Z","timestamp":1757694722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018306977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0002944018306977"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.12.007","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}